Short-seller Andrew Left said he has increased his wager against Palantir Technologies, describing the data-analytics company as "beyond overvalued." In an interview on Fox Business on 13 Aug., the Citron Research founder disclosed a fresh short position and called the trade “obvious,” even while praising both the firm and Chief Executive Officer Alex Karp. Palantir’s valuation has drawn criticism from several corners. The company posted 48% revenue growth in the second quarter and has a modest short interest of roughly 2% of shares outstanding, yet Left argued no company with a comparable market capitalization has sustained such a premium for long. The Economist recently went further, suggesting Palantir could be among the most overvalued stocks ever. Citron’s move comes amid broader anxiety over stretched equity prices. The Nasdaq now trades at about 29 times forward earnings, the S&P 500 at 23 times, and the MSCI World information-technology sector at a 27-times multiple. Roughly 23% of MSCI World constituents are priced above 10 times sales, topping levels last seen during the dot-com bubble.